Kwon Seong Young, Min Jung-Joon, Song Ho-Chun, Choi Chan, Na Kook-Joo, Bom Hee-Seung
Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 160 Ilsim-ri, Hwasun, Chonnam, 519-809 Republic of Korea.
Department of Pathology, Chonnam National University Hwasun Hospital, Chonnam, Republic of Korea.
Nucl Med Mol Imaging. 2011 Sep;45(3):185-91. doi: 10.1007/s13139-011-0085-9. Epub 2011 May 12.
Although (18)F-fluorodeoxyglucose (FDG) PET/CT has improved the accuracy of evaluating lymph node (LN) staging in non-small cell lung cancer (NSCLC), false-positive results remain a problem. The reason why benign LNs show high FDG uptake is still unclear. The aim of this study was to identify molecular and pathological characteristics of benign LNs showing high FDG uptake.
We studied 108 mediastinal LNs of pathologically benign nature obtained from 43 patients with NSCLC who underwent FDG PET/CT and surgery. We measured the following parameters in each LN: maximum standardized uptake value (maxSUV), short diameter, maximum Hounsfield unit (maxHU) value, occupied proportions of lymphoid follicles, histiocytes in extrafollicular space and the degree of glucose transporter 1 (Glut1) expression. We compared the parameters between two LN groups according to maxSUV.
There were 74 LNs showing maxSUV≥3.0 (group 1) and 34 LNs with maxSUV<3.0 (group 2). The size of LN (p < 0.001) and maxHU (p = 0.003) in group 1 was higher than that in group 2. Histologically, the occupied proportions of lymphoid follicles (p = 0.031) or histiocytes (p = 0.004) were higher in group 1. The Glut1 expression of lymphoid follicles (p = 0.035) or histiocytes (p = 0.005) was also higher in group 1.
Lymphoid follicular hyperplasia and histiocyte infiltration associated with Glut1 overexpression are important molecular and pathological mechanisms for false-positive FDG uptake in benign mediastinal LNs in patients with NSCLC.
尽管(18)F - 氟脱氧葡萄糖(FDG)PET/CT提高了评估非小细胞肺癌(NSCLC)淋巴结(LN)分期的准确性,但假阳性结果仍然是个问题。良性淋巴结显示高FDG摄取的原因尚不清楚。本研究的目的是确定显示高FDG摄取的良性淋巴结的分子和病理特征。
我们研究了43例接受FDG PET/CT和手术的NSCLC患者的108个病理性质为良性的纵隔淋巴结。我们在每个淋巴结中测量了以下参数:最大标准化摄取值(maxSUV)、短径、最大亨氏单位(maxHU)值、淋巴滤泡的占据比例、滤泡外间隙中的组织细胞以及葡萄糖转运蛋白1(Glut1)的表达程度。我们根据maxSUV比较了两组淋巴结之间的参数。
有74个淋巴结显示maxSUV≥3.0(第1组)和34个淋巴结maxSUV<3.0(第2组)。第1组淋巴结的大小(p < 0.001)和maxHU(p = 0.003)高于第2组。组织学上,第1组淋巴滤泡(p = 0.031)或组织细胞(p = 0.004)的占据比例更高。第1组淋巴滤泡(p = 0.035)或组织细胞(p = 0.005)的Glut1表达也更高。
与Glut1过表达相关的淋巴滤泡增生和组织细胞浸润是NSCLC患者良性纵隔淋巴结FDG摄取假阳性的重要分子和病理机制。